Works by Haidopoulos, Dimitrios

Results: 61
    1

    Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents.

    Published in:
    Oncology, 2013, v. 84, n. 3, p. 158, doi. 10.1159/000341366
    By:
    • Bamias, aristotle;
    • Bamia, Christine;
    • Zagouri, Flora;
    • Kostouros, Efthimios;
    • Kakoyianni, Konstantina;
    • Rodolakis, alexandros;
    • Vlahos, George;
    • Haidopoulos, Dimitrios;
    • Thomakos, Nikolaos;
    • antsaklis, aris;
    • Dimopoulos, Meletios-athanasios
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).

    Published in:
    Cancer Medicine, 2021, v. 10, n. 1, p. 208, doi. 10.1002/cam4.3605
    By:
    • Gultekin, Murat;
    • Ak, Sertac;
    • Ayhan, Ali;
    • Strojna, Aleksandra;
    • Pletnev, Andrei;
    • Fagotti, Anna;
    • Perrone, Anna Myriam;
    • Erzeneoglu, B. Emre;
    • Temiz, B. Esat;
    • Lemley, Birthe;
    • Soyak, Burcu;
    • Hughes, Cathy;
    • Cibula, David;
    • Haidopoulos, Dimitrios;
    • Brennan, Donal;
    • Cola, Edoardo;
    • Steen‐Banasik, Elzbieta;
    • Urkmez, Esra;
    • Akilli, Huseyin;
    • Zapardiel, Ignacio
    Publication type:
    Article
    10
    11
    12
    13

    What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience.

    Published in:
    Current Oncology, 2021, v. 28, n. 6, p. 4862, doi. 10.3390/curroncol28060410
    By:
    • Liontos, Michalis;
    • Svarna, Anna;
    • Theofanakis, Charalampos;
    • Fiste, Oraianthi;
    • Andrikopoulou, Angeliki;
    • Kaparelou, Maria;
    • Koutsoukos, Konstantinos;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Rodolakis, Alexandros;
    • Dimopoulos, Meletios Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    14

    BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients.

    Published in:
    Current Oncology, 2021, v. 28, n. 6, p. 4446, doi. 10.3390/curroncol28060377
    By:
    • Liontos, Michalis;
    • Zografos, Eleni;
    • Zoumpourlis, Panagiotis;
    • Andrikopoulou, Angeliki;
    • Svarna, Anna;
    • Fiste, Oraianthi;
    • Kunadis, Elena;
    • Papatheodoridi, Alkistis Maria;
    • Kaparelou, Maria;
    • Koutsoukos, Konstantinos;
    • Thomakos, Nikoloas;
    • Haidopoulos, Dimitrios;
    • Rodolakis, Alexandros;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    15
    16

    Risk factors in women 40 years of age and younger with endometrial carcinoma.

    Published in:
    Acta Obstetricia et Gynecologica Scandinavica, 2010, v. 89, n. 10, p. 1326, doi. 10.3109/00016349.2010.515666
    By:
    • HAIDOPOULOS, DIMITRIOS;
    • SIMOU, MARIA;
    • AKRIVOS, NIKOLAOS;
    • RODOLAKIS, ALEXANDROS;
    • VLACHOS, GEORGIOS;
    • FOTIOU, STELIOS;
    • SOTIROPOULOU, MARIA;
    • THOMAKOS, NIKOLAOS;
    • BILIATIS, IOANNIS;
    • PROTOPAPPAS, ATHANASIOS;
    • ANTSAKLIS, ARIS
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.

    Published in:
    PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156403
    By:
    • Trachana, Sofia-Paraskevi;
    • Pilalis, Eleftherios;
    • Gavalas, Nikos G.;
    • Tzannis, Kimon;
    • Papadodima, Olga;
    • Liontos, Michalis;
    • Rodolakis, Alexandros;
    • Vlachos, Georgios;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Lykka, Maria;
    • Koutsoukos, Konstantinos;
    • Kostouros, Efthimios;
    • Terpos, Evagelos;
    • Chatziioannou, Aristotelis;
    • Dimopoulos, Meletios-Athanasios;
    • Bamias, Aristotelis
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2.

    Published in:
    International Journal of Cancer, 2012, v. 130, n. 4, p. 857, doi. 10.1002/ijc.26094
    By:
    • Ziogas, Apostolos C.;
    • Gavalas, Nikos G.;
    • Tsiatas, Marinos;
    • Tsitsilonis, Ourania;
    • Politi, Ekaterini;
    • Terpos, Evangelos;
    • Rodolakis, Alexandros;
    • Vlahos, George;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Antsaklis, Aristidis;
    • Dimopoulos, Meletios A.;
    • Bamias, Aristotle
    Publication type:
    Article
    42

    Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer.

    Published in:
    Nutrients, 2025, v. 17, n. 3, p. 556, doi. 10.3390/nu17030556
    By:
    • Paschou, Stavroula A.;
    • Andrikopoulou, Angeliki;
    • Mili, Nikoletta;
    • Svarna, Anna;
    • Kaparelou, Maria;
    • Stefanaki, Katerina;
    • Dedes, Nikolaos;
    • Liatsou, Efstathia;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Psaltopoulou, Theodora;
    • Kastritis, Efstathios;
    • Zagouri, Flora;
    • Dimopoulos, Meletios-Athanasios;
    • Liontos, Michalis
    Publication type:
    Article
    43

    Cystic Uterine Tumors.

    Published in:
    Gynecologic & Obstetric Investigation, 2008, v. 65, n. 4, p. 275, doi. 10.1159/000113871
    By:
    • Protopapas, Athanasios;
    • Milingos, Spyros;
    • Markaki, Sophia;
    • Loutradis, Dimitrios;
    • Haidopoulos, Dimitrios;
    • Sotiropoulou, Maria;
    • Antsaklis, Aris
    Publication type:
    Article
    44
    45

    Molecular Alterations in Paired Epithelial Ovarian Tumors in Patients Treated with Neoadjuvant Chemotherapy.

    Published in:
    Cancers, 2024, v. 16, n. 21, p. 3580, doi. 10.3390/cancers16213580
    By:
    • Nikolaidi, Adamantia;
    • Papadopoulou, Eirini;
    • Haidopoulos, Dimitrios;
    • Liontos, Michalis;
    • Fountzilas, Elena;
    • Tsaousis, Georgios;
    • Goula, Kalliroi;
    • Tsolaki, Eleftheria;
    • Christopoulou, Athina;
    • Binas, Ioannis;
    • Stamatopoulou, Sofia;
    • Koumarianou, Anna;
    • Karageorgopoulou, Sofia;
    • Goussia, Anna;
    • Psyrri, Amanda;
    • Papadimitriou, Christos;
    • Gogas, Helen
    Publication type:
    Article
    46

    The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer.

    Published in:
    Cancers, 2024, v. 16, n. 11, p. 1962, doi. 10.3390/cancers16111962
    By:
    • Andrikopoulou, Angeliki;
    • Bletsa, Garyfalia;
    • Rouvalis, Angeliki;
    • Tsakogiannis, Dimitris;
    • Kaparelou, Maria;
    • Papatheodoridi, Alkistis;
    • Haidopoulos, Dimitrios;
    • Liontos, Michalis;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    47
    48
    49

    Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3519, doi. 10.3390/cancers15133519
    By:
    • Andrikopoulou, Angeliki;
    • Theofanakis, Charalampos;
    • Markellos, Christos;
    • Kaparelou, Maria;
    • Koutsoukos, Konstantinos;
    • Apostolidou, Kleoniki;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Rodolakis, Alexandros;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora;
    • Liontos, Michalis
    Publication type:
    Article
    50